Series A

Gotham goes to $54m in series A
Cornell spinout Gotham Therapeutics has come out of stealth with a series A round co-led by SR One, Versant Ventures and Forbion.
Glympse Bio engineers $22m series A
Glympse Bio, a medical diagnostic sensor spinout from MIT, has secured $22m in a series A round ahead of clinical trials targeting fatty liver disease and cancer.
StartX nurtures Kinedu in series A round
Stanford-StartX Fund has invested in childhood development app creator Kinedu, which counts childcare provider Advenio among its early backers.
Modis modulates $30m series A
Partly based on Columbia University research, Modis is advancing treatments for rare diseases caused by dysfunction in cellular mitochondria.
PervasID registers $2.1m
Cambridge Enterprise, CIC and Parkwalk have returned to back locational data technology spinout PervasID as the business targets further growth in healthcare, retail and security.
Oxbotica puts $18.5m in the tank
Autonomous vehicle software spinout Oxbotica has secured IP Group, Parkwalk Advisors and Axa XL as investors in its first publicly-disclosed funding round.
Strikingly slots in $10m series A-plus
US-based website creation tool developer Strikingly has received more than $10m in a series A-plus round that featured CAS Holding.
Growers reaps $5m series A
VTC Innovation Fund is among the investors in agricultural management software developer Growers’ latest round.

Other News

DyeMansion polishes $5m series A
3D finishing technology developer DyeMansion has been backed by UVC Partners, AM Ventures and BtoV Partners.
Avid rates $6m series A
4490 Ventures, the VC firm co-founded by Warf in 2013, has joined Beringea for customer experience software provider Avid Ratings' series A round.
HawkEye 360 locks in $14.9m series A-3
Twentyeight-Seven counts down to $65m series A
Twentyeight-Seven Therapeutics has officially launched with $65m in series A funding to commercialise oncology treatments based on research at Harvard Medical School.
Azeria pioneers $5.2m series A
SkyRyse glides steady with $25m
Air transit assistance system startup SkyRyse has accrued $25m in seed and series A funding from investors including Stanford University.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg


Not yet subscribed?

See your subscription offers here